
MTVA
Healthcare · Biotechnology · $8.6M market cap
$1.300.00 (0.0%)Nov 13, 4:00 PM EST
Next report
Time not confirmed
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now · +1.8% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 19, 2026 · upcoming | Time not confirmed | -0.73 | -0.69 | +5.9% |
| Aug 6, 2026 | After the close | -0.85 | -0.90 | -5.9% |
| May 14, 2026 | After the close | -0.75 | -0.79 | -5.3% |
| Nov 6, 2025 | Before the open | -2.75 | -1.54 | +44.0% |
| Aug 7, 2025 | Before the open | -0.32 | -0.26 | +18.8% |
| May 14, 2025 | Time not confirmed | -0.30 | -0.36 | -20.0% |
| Mar 20, 2025 | Before the open | -8.14 | -3.52 | +56.8% |
| Nov 7, 2024 | Before the open | -8.03 | -6.05 | +24.7% |
| Aug 14, 2024 | Before the open | -12.36 | -20.35 | -64.6% |
| May 9, 2024 | Time not confirmed | -3.63 | -1.32 | +63.6% |
| Mar 28, 2024 | After the close | -8.63 | -25.08 | -190.6% |
| Nov 13, 2023 | After the close | -9.68 | -7.92 | +18.2% |
| Aug 9, 2023 | After the close | -11.44 |
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, as well as completed Phase 1…
| -1.76 |
| +84.6% |
| May 12, 2023 | After the close | -55.44 | -5.28 | +90.5% |
| Mar 30, 2023 | Time not confirmed | -1.20 | 4.93 | +510.8% |
| Nov 14, 2022 | After the close | -448.80 | -308.00 | +31.4% |
| Aug 16, 2022 | Time not confirmed | -5.10 | -0.12 | +97.6% |
| May 25, 2022 | Time not confirmed | -0.16 | -0.17 | -6.3% |
| Nov 15, 2021 | Before the open | -475.20 | -422.40 | +11.1% |
| Aug 16, 2021 | Before the open | -396.00 | -475.20 | -20.0% |
| Apr 15, 2021 | After the close | -501.60 | -3168.00 | -531.6% |
| Nov 13, 2020 | After the close | -448.80 | -501.60 | -11.8% |
| Aug 11, 2020 | After the close | -712.80 | -396.00 | +44.4% |
| May 20, 2020 | After the close | -264.00 | -792.00 | -200.0% |
| Mar 30, 2020 | Time not confirmed | -2.25 | -0.73 | +67.6% |
| Dec 27, 2019 | Time not confirmed | -0.11 | -6.00 | -5354.5% |
| Aug 9, 2019 | Time not confirmed | -0.12 | -5.00 | -4066.7% |
| May 6, 2019 | Time not confirmed | -0.42 | -6.75 | -1507.1% |
| Mar 15, 2019 | Time not confirmed | -0.41 | -6.50 | -1485.4% |
| Nov 8, 2018 | Time not confirmed | -0.47 | -10.75 | -2187.2% |
| Aug 13, 2018 | Time not confirmed | -0.55 | -11.75 | -2036.4% |
| May 8, 2018 | Time not confirmed | -0.67 | -14.50 | -2064.2% |
| Mar 15, 2018 | Time not confirmed | -0.69 | -0.63 | +8.7% |